Pharma Mar, S.A.
PHMMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,782 | $1,359 | $1,410 | $1,381 |
| - Cash | $58 | $22 | $60 | $63 |
| + Debt | $59 | $51 | $52 | $51 |
| Enterprise Value | $1,783 | $1,389 | $1,402 | $1,369 |
| Revenue | $42 | $56 | $39 | $48 |
| % Growth | -25.8% | 45.1% | -19.7% | – |
| Gross Profit | $37 | $54 | $35 | $47 |
| % Margin | 87.9% | 95.1% | 91.2% | 97.3% |
| EBITDA | -$2 | $26 | -$1 | $15 |
| % Margin | -5.5% | 46.4% | -2.8% | 31.4% |
| Net Income | -$5 | $23 | -$4 | $19 |
| % Margin | -11.5% | 41.4% | -10.2% | 38.6% |
| EPS Diluted | -0.28 | 1.35 | -0.23 | 1.06 |
| % Growth | -120.7% | 687% | -121.7% | – |
| Operating Cash Flow | $20 | $9 | -$6 | $2 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$2 |
| Free Cash Flow | $18 | $8 | -$7 | -$0 |